If shorts weren't covering; RJK wasn't adding; and none of the large institutional holders were adding who bought the huge number of shares? Baffling!
Is PGEN about to be cornered by multiple players each of which buying less than 5% to avoid disclosure? RJK owns 48.1%, Merck kGa Germany owns I think 13%. That's already 61%. All you need is 9 sub 5% players.
This could get interesting especially if PGEN announce complete remission even at low doses in the upcoming data readout and/or partnership deals which Helen Sabzevari mentions in each call.